Literature DB >> 9376542

Abnormal functional lateralization of the sensorimotor cortex in patients with schizophrenia.

V S Mattay1, J H Callicott, A Bertolino, A K Santha, K A Tallent, T E Goldberg, J A Frank, D R Weinberger.   

Abstract

Previous neuroimaging studies have suggested that patients with schizophrenia fail to recruit appropriate focal patterns of cortical responses to cognitive tasks. We investigated whether patients with schizophrenia show a normal focal response to a simple motor task. Seven strongly right-handed patients with schizophrenia and seven strongly right-handed normal subjects performed motor tasks of increasing complexity. Patients were unable to recruit as focal a response even to a simple, automatic sequential finger movement task. They showed greater ipsilateral activation in the primary sensorimotor and lateral premotor regions and had a significantly lower laterality quotient than normal subjects. These phenomena increased with the complexity of the task. These results demonstrate a functional disturbance in the cortical motor circuitry of patients with schizophrenia.

Entities:  

Mesh:

Year:  1997        PMID: 9376542     DOI: 10.1097/00001756-199709080-00034

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

Review 1.  Science, medicine, and the future: functional magnetic resonance imaging in neuropsychiatry.

Authors:  C Longworth; G Honey; T Sharma
Journal:  BMJ       Date:  1999-12-11

Review 2.  [One decade of functional imaging in schizophrenia research. From visualisation of basic information processing steps to molecular-genetic oriented imaging].

Authors:  H Tost; A Meyer-Lindenberg; M Ruf; T Demirakça; O Grimm; F A Henn; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

3.  Mouse ES cells overexpressing DNMT1 produce abnormal neurons with upregulated NMDA/NR1 subunit.

Authors:  Leonardo D'Aiuto; Roberto Di Maio; K Naga Mohan; Crescenzio Minervini; Federica Saporiti; Isabella Soreca; J Timothy Greenamyre; J Richard Chaillet
Journal:  Differentiation       Date:  2011-04-13       Impact factor: 3.880

4.  Out-of-synch and out-of-sorts: dysfunction of motor-sensory communication in schizophrenia.

Authors:  Judith M Ford; Brian J Roach; William O Faustman; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2007-11-05       Impact factor: 13.382

Review 5.  Imaging genomics and response to treatment with antipsychotics in schizophrenia.

Authors:  Giuseppe Blasi; Alessandro Bertolino
Journal:  NeuroRx       Date:  2006-01

Review 6.  In vivo characterization of traumatic brain injury neuropathology with structural and functional neuroimaging.

Authors:  Brian Levine; Esther Fujiwara; Charlene O'Connor; Nadine Richard; Natasa Kovacevic; Marina Mandic; Adriana Restagno; Craig Easdon; Ian H Robertson; Simon J Graham; Gordon Cheung; Fuqiang Gao; Michael L Schwartz; Sandra E Black
Journal:  J Neurotrauma       Date:  2006-10       Impact factor: 5.269

7.  Impaired response selection in schizophrenia: evidence from the P3 wave and the lateralized readiness potential.

Authors:  Steven J Luck; Emily S Kappenman; Rebecca L Fuller; Benjamin Robinson; Ann Summerfelt; James M Gold
Journal:  Psychophysiology       Date:  2009-04-06       Impact factor: 4.016

8.  Sequential neural changes during motor learning in schizophrenia.

Authors:  Laura M Rowland; Reza Shadmehr; Dwight Kravitz; Henry H Holcomb
Journal:  Psychiatry Res       Date:  2008-04-14       Impact factor: 3.222

Review 9.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

10.  A CCA+ICA based model for multi-task brain imaging data fusion and its application to schizophrenia.

Authors:  Jing Sui; Tülay Adali; Godfrey Pearlson; Honghui Yang; Scott R Sponheim; Tonya White; Vince D Calhoun
Journal:  Neuroimage       Date:  2010-01-28       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.